Geode Capital Management LLC Raises Stock Holdings in ASP Isotopes Inc. (NASDAQ:ASPI)

Geode Capital Management LLC raised its position in ASP Isotopes Inc. (NASDAQ:ASPI) by 5.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,175,450 shares of the company’s stock after acquiring an additional 57,027 shares during the period. Geode Capital Management LLC owned approximately 1.65% of ASP Isotopes worth $5,326,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in ASPI. State Street Corp grew its holdings in shares of ASP Isotopes by 12.8% during the third quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after buying an additional 96,604 shares during the last quarter. Diametric Capital LP increased its holdings in ASP Isotopes by 4.1% in the 4th quarter. Diametric Capital LP now owns 303,855 shares of the company’s stock worth $1,376,000 after buying an additional 11,886 shares during the period. Rovida Investment Management Ltd acquired a new position in ASP Isotopes in the 4th quarter worth approximately $990,000. JPMorgan Chase & Co. raised its position in ASP Isotopes by 854.6% during the 4th quarter. JPMorgan Chase & Co. now owns 211,893 shares of the company’s stock worth $960,000 after buying an additional 189,697 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in ASP Isotopes by 31.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 158,226 shares of the company’s stock valued at $717,000 after acquiring an additional 37,948 shares during the period. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Stock Down 2.6 %

NASDAQ:ASPI opened at $5.31 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The company’s fifty day moving average price is $4.75 and its 200-day moving average price is $5.28. ASP Isotopes Inc. has a 1-year low of $1.86 and a 1-year high of $9.33. The firm has a market capitalization of $382.68 million, a P/E ratio of -8.70 and a beta of 3.44.

Insiders Place Their Bets

In related news, CEO Paul Elliot Mann sold 316,667 shares of the firm’s stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total transaction of $1,820,835.25. Following the sale, the chief executive officer now directly owns 7,948,787 shares of the company’s stock, valued at $45,705,525.25. This trade represents a 3.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Robert Ainscow sold 66,668 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total value of $374,674.16. Following the transaction, the chief operating officer now owns 1,419,992 shares of the company’s stock, valued at approximately $7,980,355.04. This represents a 4.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 766,667 shares of company stock valued at $4,358,502. Company insiders own 21.40% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.